The week in health tech, explained in plain English.Get the free newsletter →
October 4, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Finance

Crystalys Raises $130M for Gout Drug Dotinurad

By Healthcare Technology News ·

Crystalys Therapeutics has added $130 million in new financing to push its gout drug dotinurad through pivotal testing, MedCity News reports. Dotinurad is a URAT1 inhibitor, a class designed to help the body clear uric acid, the buildup of which drives the painful inflammation of gout.

Gout is one of the most common inflammatory conditions, yet treatment options remain limited and many patients fail to reach target uric acid levels on existing therapies. That gap is drawing fresh capital and dealmaking. Dotinurad works through the same mechanism as a molecule Sobi brought into its pipeline via a roughly $950 million acquisition, according to MedCity News, underscoring how large pharma is betting on the same target.

For Crystalys, the raise funds the expensive, late-stage trials needed to prove efficacy and safety before any regulatory filing. For the broader field, the money signals that investors see commercial upside in a prevalent, undertreated disease that has long lacked innovation.

Sources

More in Finance

Finance

Vanderbilt Health Operating Margin Climbs to 4.7% in FY 2026

Vanderbilt Health reported $452 million in operating income and a 4.7% operating margin in fiscal 2026, up from a 3.0% margin the prior year.

Why it matters: A near-5% margin at a major academic system signals the financial rebound underway across large nonprofit health systems after years of pandemic-era strain.

Finance

Revenue Cycle Becomes a CEO Priority at Top Health Systems

Major health systems including Providence, Ascension and Tenet are elevating revenue cycle management to a top CEO and boardroom priority.

Why it matters: When revenue cycle becomes a CEO-level strategy, it drives more investment, automation and leverage in payer talks at a time of thin hospital margins.

Finance

UChicago Medicine Shifts Staff to Harder Revenue Cycle Work

UChicago Medicine is automating routine revenue cycle tasks and shifting staff to complex cases requiring human judgment.

Why it matters: It shows how hospitals can use automation to redeploy scarce revenue cycle talent rather than just cut jobs, easing margin and staffing pressure.